Oncology Pharma Inc. (OTCMKTS:ONPH – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 27,300 shares, a growth of 45.2% from the March 15th total of 18,800 shares. Based on an average trading volume of 300,600 shares, the short-interest ratio is currently 0.1 days.

Oncology Pharma Price Performance

ONPH stock remained flat at $0.19 during trading on Tuesday. The company had a trading volume of 66,849 shares, compared to its average volume of 67,927. The stock has a 50 day moving average price of $0.28 and a 200-day moving average price of $0.47. Oncology Pharma has a 1-year low of $0.16 and a 1-year high of $3.60.

About Oncology Pharma

(Get Rating)

Oncology Pharma, Inc engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.

See Also

• Get a free copy of the StockNews.com research report on Oncology Pharma (ONPH)
• Gamida Cell Stock Jumps Over 100% on FDA Approval
• Insiders Buy EasyJet, Regularly And Repeatedly
• Bank of America Beats Earnings, Renews Investor Upside Potential
• The Analysts See A Bright Future For Sunrun
• J.B. Hunt: Economic Contraction And A Buying Opportunity

Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with MarketBeat.com's FREE daily email newsletter.